Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).

Patients who have lost their voice box through disease such as throat cancer may be able to speak immediately after a procedure to create a small opening at the throat. A novel system cuts down a ...

In collaboration with IIT Delhi, AIIMS has developed a cost-effective prosthesis for patients with throat cancer who have lost their ability to speak. The prosthesis is placed through the ...

Voice Restoration Devices Market grows from $531.29 Million (2022) to $602.75 Million (2031) at 9.58% CAGR, driven by cancer cases & TEP demand. From $531.29 Million in 2022 to $602.75 Million by 2031 ...

Patients who lose their ability to speak after surgical treatment for throat cancer may be able to regain that ability much more quickly thanks to a new device developed by researchers at the National ...

A change in Medicare reimbursement for a prosthetic device that allows people who have had their voice box removed to speak has led some providers to stop offering the device or reducing the number of ...

Wilmington, Delaware, United States, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global voice prosthesis devices market is estimated to surge at a CAGR of 4.1% from 2023 ...